Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jan 20;16(1):107.
doi: 10.3390/genes16010107.

Gene Therapy and Diabetes: A Narrative Review of Recent Advances and the Role of Multidisciplinary Healthcare Teams

Affiliations
Review

Gene Therapy and Diabetes: A Narrative Review of Recent Advances and the Role of Multidisciplinary Healthcare Teams

Nadia Khartabil et al. Genes (Basel). .

Abstract

Introduction: Gene therapy has emerged as a promising frontier in the management of diabetes, offering innovative approaches to address both type 1 and type 2 diabetes. This narrative review examines the advancements in gene therapy applications, focusing on both animal and human studies, and includes a total of 11 studies in adherence to PRISMA guidelines. These studies utilize various viral vectors, such as adeno-associated virus (AAV) and lentivirus, to deliver genes that regulate insulin production and enhance angiogenesis. This review aims to synthesize recent advancements in gene therapy for both type 1 and type 2 diabetes and its complications, and to explore the evolving role of pharmacists in this emerging field. Methods: A comprehensive search was conducted to identify relevant studies on gene therapy for diabetes. Databases such as PubMed, the Cochrane Database of Systematic Reviews, the Cochrane Central Register of Controlled Trials, and Google Scholar were queried using keywords such as "Diabetes", "gene therapy", "Type 1 diabetes", and "Type 2 diabetes". Both animal and human studies were included to provide a broad perspective on the advancements in this field. Results: Animal model studies have shown promising results, including sustained insulin production, improved glucose homeostasis, and enhanced wound healing. Human studies, though fewer in number, have reported significant advancements. Patients with diabetic neuropathy treated with plasmid VEGF and recombinant adeno-associated virus (rAAV) showed improvements in neuropathic symptoms and glycemic control. Other studies involving intramuscular injections of VM202 and bicistronic VEGF165/HGF plasmid have reported pain reduction, improved healing of ischemic lesions, and increased angiogenesis. Conclusions: Despite these encouraging results, limitations such as small sample sizes, short follow-up periods, and the necessity for more extensive clinical trials persist. Diabetes is a metabolic syndrome that requires the collaboration of a multidisciplinary team to assist in several aspects of implementing successful gene therapy. Several healthcare providers and policy makers may play a crucial role in patient education, counseling, and the management of gene therapy treatments.

Keywords: HGF (hepatocyte growth factor); VEFG (vascular endothelia growth factor); gene therapy; glycemic control; type 1 diabetes; type 2 diabetes; wound healing.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
PRISMA 2020 flow diagram [16].
Figure 2
Figure 2
Sample of the multidisciplinary team role for diabetes gene therapy.

Similar articles

Cited by

References

    1. American Diabetes Association . Statistics About Diabetes. American Diabetes Association; Arlington County, VA, USA: 2023.
    1. Blonde L., Umpierrez G.E., Reddy S.S., McGill J.B., Berga S.L., Bush M., Chandrasekaran S., DeFronzo R.A., Einhorn D., Galindo R.J., et al. American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. Endocr. Pract. 2022;28:923–1049. doi: 10.1016/j.eprac.2022.08.002. Erratum in Endocr. Pract. 2023, 29, 80–81. - DOI - PMC - PubMed
    1. Rotenstein L.S., Kozak B.M., Shivers J.P., Yarchoan M., Close J., Close K.L. The Ideal Diabetes Therapy: What Will It Look Like? How Close Are We? Clin. Diabetes. 2012;30:44–53. doi: 10.2337/diaclin.30.2.44. - DOI
    1. What Is Gene Therapy? [(accessed on 1 December 2024)]; Available online: https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-produ....
    1. Sayed N., Allawadhi P., Khurana A., Singh V., Navik U., Pasumarthi S.K., Khurana I., Banothu A.K., Weiskirchen R., Bharani K.K. Gene therapy: Comprehensive overview and therapeutic applications. Life Sci. 2022;294:120375. doi: 10.1016/j.lfs.2022.120375. - DOI - PubMed

LinkOut - more resources